Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage

W J Slichenmyer1, W G Nelson, R J Slebos

  • 1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287.

Cancer Research
|September 15, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of microtopographic variation and macroalgal cover on morphometrics and survival of the annual form of eelgrass (<i>Zostera marina</i>).

Aquatic botany·2018
Same author

Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.

Prostate cancer and prostatic diseases·2015
Same author

Association of serum inorganic phosphate with sex steroid hormones and vitamin D in a nationally representative sample of men.

Andrology·2014
Same author

A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Racial variation in sex steroid hormone concentration in black and white men: a meta-analysis.

Andrology·2014
Same author

Association between endogenous sex steroid hormones and inflammatory biomarkers in US men.

Andrology·2013
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026
Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026
See all related articles

Loss of the G1 cell cycle checkpoint in mammalian cells does not increase sensitivity to DNA damage. This suggests p53-dependent apoptosis is cell-type specific, impacting outcomes of p53 dysfunction.

Area of Science:

  • Cell Biology
  • Genetics
  • Molecular Biology

Background:

  • Cell cycle checkpoints are crucial for maintaining genomic stability.
  • Loss of the G2 checkpoint in yeast (rad9 mutation) increases sensitivity to DNA damage and genetic instability.
  • The role of G1 checkpoint loss in mammalian cells regarding DNA-damaging agent sensitivity is less understood.

Purpose of the Study:

  • To investigate whether loss of a G1 checkpoint in mammalian cells affects sensitivity to DNA-damaging agents.
  • To determine if p53 functional status influences sensitivity to ionizing radiation and camptothecin.
  • To explore the cell type specificity of p53-dependent apoptosis.

Main Methods:

  • Comparison of clonogenic survival in isogenic mammalian cells with differing p53 functional status.

Related Experiment Videos

  • Exposure to ionizing radiation and camptothecin (a topoisomerase I inhibitor).

    • Main Results:

    • Loss of a G1 checkpoint in mammalian cells did not result in increased sensitivity to ionizing radiation.
    • Mammalian cells lacking a G1 checkpoint also showed no increased sensitivity to camptothecin.
    • These findings contrast with yeast G2 checkpoint mutants, indicating checkpoint deficiency does not universally confer DNA-damaging agent sensitivity.
    • Observations suggest p53-dependent apoptosis is cell type-specific.

    Conclusions:

    • Increased sensitivity to DNA-damaging agents is not an inherent feature of all mammalian cell cycle checkpoint deficiencies.
    • The biological consequences of p53 loss are likely cell type-specific, particularly concerning apoptosis.
    • This implies that therapeutic strategies targeting p53 function may need to consider cell-specific responses.